Latest Articles

Publication Date
Accessory cavitated uterine mass presenting as refractory dysmenorrhoea: a diagnostic challenge.

A woman in her 20s presented with severe progressive dysmenorrhoea that began within 1-2 years of menarche, was refractory to medical therapy and required repeated emergency department visits for parenteral …

Published: Sept. 24, 2026, midnight
CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells - themarijuanaherald.com

CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells themarijuanaherald.com

Published: Sept. 23, 2026, 5:01 p.m.
CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells - The Marijuana Herald

CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells The Marijuana Herald

Published: Sept. 23, 2026, 5:01 p.m.
Can this new endometriosis drug change therapy? What women need to know - The Indian Express

Can this new endometriosis drug change therapy? What women need to know The Indian Express

Published: Sept. 23, 2026, 2:04 a.m.
Contemporary menopausal hormone therapy and thrombotic disease: nationwide nested case-control study.

To investigate associations between current use of menopausal hormone therapy and development of venous thromboembolism, ischaemic stroke, and myocardial infarction.

Published: Sept. 23, 2026, midnight
Arimoclomol-loaded Pluronic F127 nanomicelles in experimental endometriosis: drug incorporation, in vitro release, and early morphological and histological responses.

Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by ectopic endometrial-like glands and stroma, persistent pelvic inflammation, pain, infertility, and frequent recurrence. The limited availability of nonhormonal and lesion-directed therapies …

Published: Sept. 23, 2026, midnight
Targeted nanotherapy shows endometriosis promise - FemTech World

Targeted nanotherapy shows endometriosis promise FemTech World

Published: Sept. 22, 2026, 1:01 p.m.
Evaluating the impact of cannabinoid extracts on chronic pain and quality of life in endometriosis patients - a pilot study.

Endometriosis is a chronic gynecological disorder characterized by persistent pain and impaired quality of life, with limited effective treatment options. Emerging evidence indicates that cannabinoids may provide analgesic and symptom-relieving …

Published: Sept. 22, 2026, midnight
Thoracic and Umbilical Endometriosis Concurrently Presenting During Secondary Subfertility Evaluation.

Thoracic endometriosis is a rare manifestation of extra pelvic endometriosis and it is often missed because of its variable clinical presentation. A 33-year-old woman undergoing evaluation for secondary subfertility presented …

Published: Sept. 22, 2026, midnight
Nutrition and Endometriosis: Current Evidence on Dietary Risk Factors and Clinical Impact - A Narrative Review.

Endometriosis (EM) is a severe chronic inflammatory disease characterized by the presence of endometrium-like tissue outside the uterine cavity, causing pain and significantly reducing quality of life. Worldwide, around 10% …

Published: Sept. 22, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!